PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
13.78%
Revenue growth below 50% of VET's 48.79%. Michael Burry would check for competitive disadvantage risks.
14.97%
Cost growth 50-75% of VET's 24.76%. Bruce Berkowitz would examine sustainable cost advantages.
12.45%
Gross profit growth below 50% of VET's 60.79%. Michael Burry would check for structural issues.
-1.17%
Margin decline while VET shows 8.07% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.94%
Other expenses growth less than half of VET's 63.39%. David Dodd would verify if advantage is sustainable.
13.17%
Operating expenses growth above 1.5x VET's 5.99%. Michael Burry would check for inefficiency.
14.47%
Similar total costs growth to VET's 15.64%. Walter Schloss would investigate norms.
No Data
No Data available this quarter, please select a different quarter.
6.11%
D&A growth 1.25-1.5x VET's 4.26%. Martin Whitman would scrutinize asset base.
9.73%
EBITDA growth below 50% of VET's 63.81%. Michael Burry would check for structural issues.
-33.61%
EBITDA margin decline while VET shows 10.09% growth. Joel Greenblatt would examine position.
12.10%
Operating income growth below 50% of VET's 109.92%. Michael Burry would check for structural issues.
-1.48%
Operating margin decline while VET shows 41.09% growth. Joel Greenblatt would examine position.
92.83%
Other expenses growth above 1.5x VET's 54.51%. Michael Burry would check for concerning trends.
379.91%
Pre-tax income growth exceeding 1.5x VET's 221.05%. David Dodd would verify competitive advantages.
321.78%
Pre-tax margin growth exceeding 1.5x VET's 115.78%. David Dodd would verify competitive advantages.
107.84%
Similar tax expense growth to VET's 113.87%. Walter Schloss would investigate patterns.
1213.67%
Net income growth exceeding 1.5x VET's 290.48%. David Dodd would verify competitive advantages.
1054.55%
Net margin growth exceeding 1.5x VET's 162.44%. David Dodd would verify competitive advantages.
1258.33%
EPS growth exceeding 1.5x VET's 286.84%. David Dodd would verify competitive advantages.
1258.33%
Diluted EPS growth exceeding 1.5x VET's 289.19%. David Dodd would verify competitive advantages.
-2.45%
Share count reduction while VET shows 1.95% change. Joel Greenblatt would examine strategy.
-2.76%
Diluted share reduction while VET shows 1.41% change. Joel Greenblatt would examine strategy.